SEC 13F Intelligence

Meadowbrook Wealth Management, LLC / VKTX

Meadowbrook Wealth Management, LLC’s Viking Therapeutics Inc Position

Does Meadowbrook Wealth Management, LLC own Viking Therapeutics Inc (VKTX)? Not currently — the last reported position was 37.2K shares worth $1M in Q4 2025; the fund’s latest 13F (Q2 2026) no longer reports it.

Position Value
$1M
Q4 2025
Shares
37.2K
% of Portfolio
+1.49%
Quarters Held
1
position exited

Position History VKTX

Reported value by quarter
Q4 ’25: $1MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202537.2K$1M+1.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meadowbrook Wealth Management, LLC’s full portfolio or all institutional holders of VKTX.